It is possible that many patients with AFP less than 100 ng/mL fall into one of two groups: patients with pathology that is actually rhabdoid or other non-HB tumor or patients in subgroups less likely to confer poor outcomes (erroneously low AFP levels due to the “hook” effect or small low-risk PRETEXT I HB tumors). This evidence concerns the gene AFP and neoplasm.